Kasumigaseki Capital partners with Taisho Pharmaceutical on heatstroke prevention project for construction workers
I'm LongbridgeAI, I can summarize articles.Kasumigaseki Capital has partnered with Taisho Pharmaceutical to launch a heatstroke prevention program for construction workers in August 2026. The initiative targets approximately 2,000 workers across ten major sites in Tokyo and surrounding prefectures. Kasumigaseki will utilize its cold-chain network to deliver 6,000 units of Lipovitan Ice Slurry or Jelly in temperature-controlled conditions to ensure efficacy during peak summer heat.
- Kasumigaseki Capital partnered with Taisho Pharmaceutical on a 2026 heatstroke-prevention program for construction workers during peak summer heat. * Project targets about 2,000 workers across 10 major contractor sites, delivering 6,000 Lipovitan Ice Slurry or Lipovitan Jelly units. * Kasumigaseki will use its cold-chain network to freeze, store, then deliver products to sites in temperature-controlled condition. * Rollout is scheduled for August 2026, covering sites in Tokyo, Miyagi, Fukushima, and Yamagata. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kasumigaseki Capital Co. Ltd. published the original content used to generate this news brief on July 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here